MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
0.9405
-0.0795
-7.79%
After Hours: 0.9405 0 0.00% 16:10 07/02 EDT
OPEN
0.9961
PREV CLOSE
1.020
HIGH
1.000
LOW
0.9163
VOLUME
97.42K
TURNOVER
--
52 WEEK HIGH
1.346
52 WEEK LOW
0.6546
MARKET CAP
34.27M
P/E (TTM)
-4.1124
1D
5D
1M
3M
1Y
5Y
1D
Dyadic International allowed claims by Japan Patent Office
TipRanks · 5d ago
Dyadic Announces Japan Patent Office Allowance Of Claims Covering Its Proprietary Thermothelomyces Heterothallica Recombinant Protein Expression Technology
Benzinga · 5d ago
Dyadic says Japan patent office allows claims for Thermothelomyces protein expression technology
PUBT · 5d ago
Weekly Report: what happened at DYAI last week (0622-0626)?
Weekly Report · 5d ago
Dyadic Expands IP Protection and Business Development Activities in Japan
Barchart · 5d ago
Dyadic Shareholders Approve Reverse Split and Governance Proposals
TipRanks · 06/22 13:45
Dyadic International shareholders approve reverse stock split authorization
PUBT · 06/22 12:31
Weekly Report: what happened at DYAI last week (0615-0619)?
Weekly Report · 06/22 09:03
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.